Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Glaukos (GKOS) R&D In Process (2017 - 2022)

Glaukos (GKOS) has disclosed R&D In Process for 4 consecutive years, with $10.0 million as the latest value for Q2 2022.

  • On a quarterly basis, R&D In Process rose 100.0% to $10.0 million in Q2 2022 year-over-year; TTM through Dec 2022 was $15.0 million, a 50.0% increase, with the full-year FY2022 number at $10.0 million, changed 0.0% from a year prior.
  • R&D In Process was $10.0 million for Q2 2022 at Glaukos, up from $5.0 million in the prior quarter.
  • In the past five years, R&D In Process ranged from a high of $10.0 million in Q2 2022 to a low of $1.5 million in Q3 2019.
  • A 3-year average of $4.7 million and a median of $5.0 million in 2021 define the central range for R&D In Process.
  • Biggest YoY gain for R&D In Process was 100.0% in 2022; the steepest drop was 100.0% in 2022.
  • Glaukos' R&D In Process stood at $1.5 million in 2019, then soared by 233.33% to $5.0 million in 2021, then surged by 100.0% to $10.0 million in 2022.
  • Per Business Quant, the three most recent readings for GKOS's R&D In Process are $10.0 million (Q2 2022), $5.0 million (Q3 2021), and $5.0 million (Q2 2021).